Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart - Baron Hoffmann - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-28 14:04:13		Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart Add to Reading List Source URL: www.curesma.org Download Document from Source Website File Size: 315,74 KB Share Document on Facebook